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The melanocortin system is a critical component of the forebrain and hindbrain regulatory
systems involved in energy balance. This system is composed of pro-opiomelanocortin
(POMC) neurons that act, in part, through the melanocortin-4 receptor (MC4R). Although
the importance of the melanocortin system in controlling feeding has been established
for two decades, the understanding of the developmental substrates underlying POMC
and MC4R neuron development and function has just begun to emerge. The formation of
the melanocortin system involves several discrete developmental steps that include the
birth and fate specification of POMC- and MC4R-containing neurons and the extension
and guidance of POMC axons to their MC4R-expressing target nuclei. Each of these devel-
opmental processes appears to require specific sets of genes and developmental cues
that include perinatal hormones. Recent evidence has also highlighted the importance of
perinatal nutrition in controlling the ultimate architecture of the melanocortin system.
Keywords: pro-opiomelanocortin, αMSH, MC4R, hypothalamus, development, hormones, axon guidance, neuro-
genesis
INTRODUCTION
Pro-opiomelanocortin (POMC) neurons control a variety of phys-
iological functions, the most characterized of which is the regu-
lation of energy balance. They reduce food intake and increase
energy expenditure by releasing α-melanocyte-stimulating hor-
mone (αMSH), a product of POMC processing (Cone, 2006;
Ellacott and Cone, 2006). More recent targeted deletion stud-
ies have specifically shown the importance of POMC neurons in
mediating the physiological actions of metabolic hormones, such
as leptin and insulin (Belgardt and Brüning, 2010; Williams and
Elmquist, 2012). POMC neurons have a limited distribution across
the central nervous system (CNS). POMC cell bodies are found
only in two CNS nuclei: the arcuate nucleus of the hypothalamus
(ARH) in the forebrain and the nucleus of the tractus solitarius
(NTS) in the brain stem (Joseph et al., 1983; Cone, 2005). Recent
data indicated that while hypothalamic POMC neurons appear to
be more involved in integrating long-term adiposity signals, the
contribution of hindbrain POMC neurons seem to be more spe-
cific to the integration of short-term satiety signals (Zhan et al.,
2013). POMC neurons provide extensive projections to various
parts of the brain, especially to the paraventricular (PVH) and
dorsomedial (DMH) nuclei of the hypothalamus, the lateral hypo-
thalamic area (LHA), and the ventral tegmental area (VTA). Each
of these nuclei and areas also plays a major role in the central regu-
lation of feeding behavior and energy balance (King and Hentges,
2011) (Figure 1).
Of the five known melanocortin receptors (MCRs), αMSH
binds with various affinities to MC1R, MC3R, MC4R, and MC5R.
However, it is the MC4R subtype that has been primarily impli-
cated in the regulation of energy balance. The observation that
deletion of the MC4R results in a phenotype that is a virtual
carbon copy of POMC-deficient mice (including late onset of obe-
sity and diabetes) strongly supports this idea (Huszar et al., 1997;
Yaswen et al., 1999; Butler et al., 2001; Challis et al., 2004). Notably,
mutations in the MC4R gene are the most common monogenic
disorders that cause obesity in humans (Coll et al., 2007). MC4R is
a G-protein-coupled receptor that has a widespread distribution
throughout the CNS. MC4R mRNA is found in virtually every
part of the brain, including the hypothalamus, thalamus, cortex,
brainstem, and spinal cord (Mountjoy et al., 1994; Kishi et al.,
2003). Soon after the cloning of the MC4R, agouti-related protein
(AgRP), which is synthesized in the ARH, has been identified as an
endogenous antagonist of the MC4R (Huszar et al., 1997; Ollmann
et al., 1997).
This review attempts to summarize our current understanding
of the development of the melanocortin system within the context
of metabolic programing. Because of the lack of data on the devel-
opment of POMC neurons in the NTS, this review will largely
focus on the development of arcuate POMC neurons and their
related hypothalamic MC4R pathways.
DEVELOPMENT OF THE MELANOCORTIN SYSTEM
The developmental processes that produce the melanocortin sys-
tem can fall into two broad categories: the birth and determination
of the neuronal phenotype of POMC- and MC4R-containing neu-
rons and the formation of functional circuits, which includes
POMC axon growth and synaptogenesis onto MC4R-responsive
targets.
NEUROGENESIS
Classic experiments that used birth dating tools, such as the thymi-
dine analog bromodeoxyuridine, revealed that the majority of
POMC neurons in the mouse ARH are born primarily on embry-
onic day (E)11–E12 (Khachaturian et al., 1985; Padilla et al., 2010).
However, some POMC neurons, which are located more later-
ally in the ARH, are generated as late as E13. Gene expression
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FIGURE 1 | Architecture and development of the POMC neural system
in the mouse. POMC neurons located in the arcuate nucleus of the
hypothalamus (ARH) send direct projections to discrete populations of
neurons located in the dorsomedial (DMH) and paraventricular nuclei (PVH)
of the hypothalamus and to the lateral hypothalamic area (LHA). Each of
these regions plays a major role in the control of energy balance and
feeding behavior. ARH POMC neurons are born at E11–E12 and innervate
their target nuclei primarily during the first 2 weeks of postnatal life.
studies have also shown that neurons in the presumptive ARH first
express POMC mRNA on E10–E12 (Padilla et al., 2010) (Figure 2),
which is consistent with early determination of cell fate. Recent
genetic cell lineage tracing studies confirmed this hypothesis and
revealed that POMC neurons acquire their terminal phenotype
at approximately E15 (Padilla et al., 2010). However, only a por-
tion of embryonic Pomc-expressing precursors adopts a POMC
fate in adult mice. Half of Pomc-expressing precursors acquire
a non-POMC fate in adult mice and nearly one quarter of the
mature NPY neurons in the ARH share a common progenitor with
POMC cells (Padilla et al.,2010). These data show the unique prop-
erty of Pomc-expressing progenitors with respect to giving rise to
antagonistic neuronal populations.
DEVELOPMENT OF POMC-CONTAINING AXONAL PROJECTION
The ontogeny of the POMC neuronal projections remains to be
determined specifically. However, axonal tract tracing experiments
in mice have revealed that ARH projections are largely immature at
birth and develop postnatally during the first 2 weeks of postnatal
life. By P6, ARH projections extend through the periventricular
zone of the hypothalamus to provide inputs to the DMH first,
followed by inputs to the PVH between P8 and P10. Projections
from the ARH to the LHA develop significantly later, with the
mature pattern of innervation first apparent on P12. Not until P18
does the pattern of ARH axonal projections achieve a distribution
that resembles that seen in the adult (Bouret et al., 2004a). These
findings suggest that the development of ARH POMC axonal pro-
jections toward each of their target nuclei does not occur until the
second week of postnatal life, i.e., at a time that is far removed
from the birth of these neurons (E11–E12). At the synaptic levels,
Colmers and collaborators showed that there is an age-dependent
increase in the electrophysiological response of specific sets of PVH
neurons to melanocortin, with a maximal response observed at
FIGURE 2 | Developmental regulation of the melanocortin system. Low
levels of Pomc mRNA are found in the hypothalamus as early as embryonic
day (E)12, i.e., soon after the birth of POMC neurons. Pomc mRNA exhibits
a peak of expression on E14. POMC neurons act in part through the
melanocortin-4 receptor (MC4R) to exert their effects. Mc4r mRNA is also
found in the hypothalamus as early as on E12 and display a peak of
expression on E16.
P28–P35 (Melnick et al., 2007). These results suggest that synapses
between POMC axons and PVH MC4R-containing neurons are
not structurally and functionally mature until puberty.
DEVELOPMENTAL REGULATION OF MC4R
In spite of the importance of MC4R in energy balance regulation,
we still know relatively little about the exact time point at which
the assembly of this system is fully established. For example, we
still do not know when MC4R neurons are born or when MC4R
becomes functional and able to signal. Nevertheless, the fact that
peripheral injection of the MCR agonist MTII reduces milk intake
and body weight as early as during the first 2 weeks of postnatal life
suggests that MC4R receptors might be present and functional in
the hypothalamus at this age (Glavas et al., 2007). Consistent with
this idea, in situ hybridization analysis shows that MC4R mRNA
is abundant in the hypothalamus and especially in the PVH at P10
(Figure 2). That peripheral injection of MTII induces strong acti-
vation of cFos immunoreactivity (a marker of neuronal activation)
in the PVH at P5–P15 further supports the functionality of MC4R
in the PVH during early postnatal life (Glavas et al., 2007). At the
molecular level, it was shown that MC4R mRNA is first expressed
at E12 in the proliferative zone surrounding the lower portion of
the third ventricle (also known as the neurepithelium) and that
this mRNA expression peaks at E16 (Figure 2) (Mountjoy and
Wild, 1998). These findings are particularly interesting because it
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is known that neurons that compose various hypothalamic nuclei
in adults are primarily derived from precursors that originate from
this proliferative zone, raising the possibility that MC4R could be
involved in hypothalamic neurogenesis. Supporting this hypothe-
sis, melanocortins stimulate astrocyte proliferation in vitro (Zohar
and Salomon, 1992). Other brains sites express MC4R during
embryonic development. In addition to being expressed in the
diencephalic neurepithelium, MC4R mRNA is also found in the
telencephalon and the lamina terminalis at E14 (Mountjoy and
Wild, 1998). By E19, MC4R mRNA is widely expressed throughout
the brain (Mountjoy and Wild, 1998).
HORMONAL REGULATION OF POMC NEURONS DURING
EARLY LIFE
Accumulating evidence suggests that there are physiological dif-
ferences in the regulation of energy balance between adults and
neonates. For example, in sharp contrast to the effects of leptin
on adults, several groups have reported that exogenous leptin does
not significantly inhibit growth, food intake, or energy expenditure
until after weaning (Mistry et al., 1999; Ahima and Hileman, 2000;
Schmidt et al., 2001; Proulx et al., 2002). Similarly, in contrast to the
well-known orexigenic effects of ghrelin in mature animals, exoge-
nous ghrelin does not significantly promote milk intake in the first
2–3 postnatal weeks (Piao et al., 2008; Steculorum and Bouret,
2011a). The general thinking has been that the neonatal brain is
relatively insensitive to metabolic hormones. However, both lep-
tin and ghrelin receptors are expressed in the ARH during early
postnatal life (Caron et al., 2010; Steculorum and Bouret, 2011a)
and these receptors can initiate cellular responses, particularly in
POMC neurons. First, acute peripheral leptin treatment in mice on
P10 induces phosphorylation of STAT3 and ERK (two major leptin
receptor signaling pathways) in 20–35% of ARH POMC neurons
(Caron et al., 2010; Bouret et al., 2012). The same leptin treatment
increases Pomc mRNA levels in the rat ARH (Proulx et al., 2002).
Second, acute peripheral ghrelin treatment in P10 mice causes
a reduction in Pomc gene expression in the ARH (Steculorum
and Bouret, 2011a). Collectively, these findings provide convinc-
ing evidence that POMC neurons contain functional receptors for
metabolic hormones such as leptin and ghrelin during the postna-
tal period, and suggest that the “hormone insensitivity” observed
during this period could instead be from a failure of these cells to
relay hormonal signals to other parts of the hypothalamus.
MECHANISMS UNDERLYING POMC NEURON DEVELOPMENT
The process of developing highly specialized cellular structures,
such as POMC neurons require tight temporal and regional reg-
ulation of expression for specific sets of genes and developmental
cues. A variety of genetic tools are now available to specifically
identify the cellular and molecular pathways that are involved in
POMC neuronal development.
MECHANISMS UNDERLYING CELL FATE SPECIFICATION: THE ROLE OF
TRANSCRIPTION FACTORS
While the specific programs involved in the determination of
POMC terminal fates are unknown, recent data investigating the
role of the Mash1-neurogenin 3 (Ngn3) pathway provides some
clues as to the role of these transcription factors in the differ-
entiation of the POMC lineage. Using a mouse model of Mash1
deficiency (Mash1−/−mice), McNay et al. (2006) found that this
basic helix-loop-helix transcription factor has a pro-neural func-
tion and act upstream of Ngn3 to regulate neurogenesis in the
ventral hypothalamus. Loss of Mash1 blunts Ngn3 expression in
ARH progenitors and is associated with a dramatic reduction in
the number of POMC-expressing cells at E12. More recent genetic
fate mapping and loss of function studies in mice further demon-
strated that the expression of Ngn3 in progenitor cells promotes
the development of arcuate POMC neurons (Pelling et al., 2011).
Based on the recent observations that a subset of Pomc-expressing
progenitors in the ARH differentiates into functional mature NPY
neurons (Padilla et al., 2010), it would also be interesting to deter-
mine the molecular mechanisms that underlie this developmental
switch.
CUES INVOLVED IN AXON GROWTH AND AXON GUIDANCE
The precise molecular mechanisms that are responsible for the
formation of POMC circuits are only beginning to be understood.
In general, axon development comprises two aspects: the phys-
ical act of extension and the molecular mechanisms underlying
this process. Axons grow by sending out a highly plastic and sen-
sitive structure called a “growth cone,” which travels toward the
target and trails behind it the elongating neurite. As noted above,
neonatal POMC neurons express LepRb, and the administration of
leptin to mouse neonates results in the activation of major LepRb
signaling pathways, including pSTAT3 and pERK in POMC neu-
rons, specifically (Caron et al., 2010; Bouret et al., 2012). Recent
anatomical data showed that one of the key factors in control-
ling the development of POMC neural circuits appears to be the
expression of LepRb by POMC neurons (Table 1). Direct expo-
sure of ARH explants in vitro to leptin promotes axon growth
(Bouret et al., 2004b). In addition, mice or rats that lack functional
LepRb signaling (Leprdb/Leprdb mice and fa/fa rats, respectively)
display a reduced density of ARH POMC projections to the PVH
(Bouret and Simerly, 2007; Bouret et al., 2012). Similarly, the den-
sity of αMSH-immunoreactive fibers is also markedly reduced in
the PVH of s/s mice that lack functional LepRb→ STAT3 signal-
ing (Bouret et al., 2012). This observation raises the importance of
this signaling pathway, specifically, in the development of POMC
neural projections. However, not all LepRb signaling pathways
play a role in the formation of POMC projections. For example,
Table 1 | List of genetic and pathological conditions that alter
development of POMC-derived neural projections.
Animal model Reference
Leptin-deficient (Lepob/Lepob) mouse Bouret et al. (2004b)
Leptin receptor (Leprdb/Leprdb) null mouse Bouret et al. (2012)
LepRb→pSTAT3 (s/s) null mouse Bouret et al. (2012)
Obese (fa/fa) Zucker rat Bouret and Simerly (2007)
Obesity-prone DIO rat Bouret et al. (2008)
Maternal obesity Kirk et al. (2009)
Maternal diabetes Steculorum and Bouret (2011b)
Maternal caloric restriction Delahaye et al. (2008)
Maternal low-protein diet Coupe et al. (2010)
Postnatal overfeeding Bouret et al. (2007)
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mice that lack LepRb→ ERK signaling (l/l mice) display com-
parable densities of αMSH-immunoreactive fibers in the PVH
compared to wild-type mice (Bouret et al., 2012). Of particular
importance is the fact that leptin appears to exert its develop-
mental action on POMC neural projections during a discrete
developmental critical period. POMC neuronal projections are
disrupted in leptin-deficient (Lepob/Lepob) mice, and exogenous
leptin treatment during the first 2 weeks of postnatal life rescues
these projections (Bouret et al., 2004b). In contrast, the treat-
ment of adult Lepob/Lepob mice with leptin is relatively ineffective
and does not increase the density of αMSH fibers in the PVH
to levels that are characteristic of wild-type mice (Bouret et al.,
2004b).
Growing POMC axons must then choose a path to follow
and must decide the direction to go on this path to innervate
the proper nucleus (e.g., the PVH). The pathways are defined by
cell–cell interactions and diffusible chemorepulsive and chemoat-
tractive cues (Tessier-Lavigne and Goodman, 1996). Notably, the
diffusible axon guidance cues Netrin, Slit, and Semaphorins are
highly expressed in the PVH during development (Xu and Fan,
2008), and POMC terminals express the semaphorin receptor
neuropilin 1 (LeGuern and Bouret, unpublished data). Support-
ing a role for neuropilins/semaphorins in POMC axon guidance,
a loss of neuropilin 1 receptors in POMC neurons disrupts the
development of POMC axonal projections to the PVH, specifi-
cally (LeGuern and Bouret, unpublished data). The formation of
POMC neural connections also likely involves cell adhesion mol-
ecules. Supporting this idea, mice that are deficient in contactin, a
cell adhesion molecule that is involved in the formation of axonal
projections, display reduced density of αMSH-immunoreactive
fibers in the PVH during postnatal development (Fetissov et al.,
2005).
CELLULAR MECHANISMS INVOLVED IN POMC NEURON
DEVELOPMENT: ROLE OF AUTOPHAGY
The development of POMC neurons also requires massive cyto-
plasmic remodeling. Autophagy is one of the major cellular degra-
dation processes in which parts of the cytoplasm and intracel-
lular organelles are engulfed within double-membraned vesicles,
known as autophagosomes (Klionsky, 2007). An important func-
tion of autophagy is to promote cell growth, development, and
homeostasis, by maintaining a balance between the synthesis,
degradation, and subsequent recycling of cellular components
(Levine and Klionsky, 2004; Maiuri et al., 2007; Cecconi and
Levine, 2008). Recent morphological data revealed that autophagy
is constitutively present in the hypothalamus during important
periods of development, including in POMC neuron perikarya
and processes such as dendrites (Coupe et al., 2012). Consis-
tent with a functional role for autophagy in POMC neurons,
conditional deletion of essential autophagy genes, such as the
autophagy-related gene (Atg) 7, results in obesity and impaired
glucose homeostasis (Coupe et al., 2012; Kaushik et al., 2012; Quan
et al., 2012). These metabolic disturbances are associated with neu-
rodevelopmental abnormalities. Neonates lacking ATG7 in POMC
neurons display a reduced density of POMC-containing projec-
tions to each of their target nuclei, including the PVH, DMH, and
LHA (Coupe et al., 2012). These structural abnormalities persist
throughout adult life and appear to be the result of a diminished
capacity of POMC neurons for extending axons (Coupe et al.,
2012). However, not all of the developmental processes are affected
by autophagy deficiency. No changes in POMC cell numbers
were reported in mice that lacked autophagy in POMC neurons
(Coupe et al., 2012; Kaushik et al., 2012; Quan et al., 2012), which
suggests that autophagy does not influence neurogenesis or pro-
gramed cell death and that instead it has a specific role in axon
growth.
PATHOLOGICAL CONDITIONS THAT ALTER MELANOCORTIN
SYSTEM DEVELOPMENT
MATERNAL OBESITY AND/OR DIABETES
In the United States, epidemiological studies have estimated that
20% of women are obese when they conceive (Johnson et al., 2006).
This disturbing observation highlights the importance of evaluat-
ing the outcomes of maternal obesity in the offspring. Maternal
high-fat diet (HFD) feeding during pregnancy is most likely the
most widely used approach for studying the consequences of
maternal obesity. Notably, offspring born to obese females fed
an HFD (45–60% of calories from fat) during gestation only or
during both gestation and lactation become progressively over-
weight, hyperphagic, and glucose intolerant, and they display an
increase in adiposity (Chen et al., 2009; Kirk et al., 2009). The
model of diet-induced obesity (DIO) developed by Levin et al.
(1997) also provides a valuable tool for the study of obesity, in part
because Levin’s DIO rats share several features with human obesity,
including polygenic inheritance. This animal model is therefore
particularly well suited for the study of the relative contribution
of genetic versus environmental factors in metabolic program-
ing. Impaired organization of POMC neural circuits is a common
feature of maternal obesity (Table 1). Animals born to either
high-fat fed or obese-prone DIO dams display a reduced den-
sity of αMSH fibers innervating the PVH (Bouret et al., 2008; Kirk
et al., 2009). In DIO rats, the abnormal development of POMC
projections appears to be the result of a diminished response
to the neurotrophic action of leptin during the early postnatal
period (Bouret et al., 2008). In addition, a significant remodel-
ing of synapses onto POMC neurons has been observed in DIO
rats, particularly in response to nutritional challenges (Horvath
et al., 2010). DIO rats fed a chow diet display increased inhibitory
inputs to POMC neurons compared to obesity-resistant DR rats.
In addition, DIO rats fed a HFD display a loss of synapses onto
POMC neurons, whereas high-fat feeding in control (DR) rats
causes an increase in POMC synaptic coverage (Horvath et al.,
2010).
However, one caveat to keep in mind is that almost all of
the animal models of maternal obesity are also hyperglycemic
and insulin-resistant. This complication makes it difficult to dif-
ferentiate the detrimental effects of maternal obesity per se as
opposed to maternal diabetes. Nevertheless, the manipulation of
glucose and insulin levels without an alteration of the diet can
be performed experimentally by injecting streptozotocin, a pan-
creatic beta-cell toxin. Using this approach, we recently found
that maternal diabetes alone (i.e., without maternal obesity) can
cause a reduction in the density of αMSH-immunoreactive pro-
jections to the PVH (Steculorum and Bouret, 2011b) (Table 1).
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Importantly, an increase in the POMC cell number is observed in
the ARH of pups that were born to diabetic dams (Steculorum
and Bouret, 2011b), which supports the hypothesis that the low
density of POMC-derived fibers is more likely the result of alter-
ations in POMC axon growth as opposed to a reduction in cell
numbers.
MATERNAL MALNUTRITION
Interest in maternal malnutrition is also particularly high given its
high prevalence in underdeveloped countries and the evidence
regarding its disease-promoting potential in offspring. Animal
models commonly used to study the consequences of maternal
malnutrition include caloric restriction and a low-protein diet
during pregnancy and lactation. Maternal malnutrition (caused
either by caloric restriction or a low-protein diet) affects the
overall organization of POMC neural circuits by altering the den-
sity of αMSH-containing axons (Delahaye et al., 2008; Coupe
et al., 2010) (Table 1). However, if pups born to malnourished
dams do not exhibit a rapid catch-up growth, this reduction of
POMC innervation is associated with an increased sensitivity to
the anorexigenic effect of the melanocortin agonist MTII (Stocker
et al., 2012). Therefore, the timing of catch-up growth appears
to be an important determinant for the lifelong regulation of the
melanocortin system. Supporting this hypothesis, although early
catch-up growth ameliorates the abnormal organization of POMC
pathways observed in pups born to protein-restricted dams and
is highly beneficial for markers of brain development, including
markers of cell adhesion and axon elongation, late catch-up growth
causes permanent structural defects of POMC neural projections
(Coupe et al., 2010).
POSTNATAL OVERFEEDING/OBESITY
Because of the importance of hypothalamic development during
postnatal life, including the melanocortin system, in rodents, ani-
mal models of postnatal metabolic programing are particularly
relevant. An animal model that has proven to be extremely fruit-
ful for the study of postnatal overfeeding is the divergent litter
size model. In this model, pups are raised in small litters (SL)
from birth to weaning to induce accelerated growth during the
pre-weaning period. Postnatally overfed animals show increased
adult body weight and an accelerated and exacerbated weight gain
when fed an HFD (Glavas et al., 2010). Chronic postnatal over-
feeding is associated with a reduced activity of the melanocortin
system. For example, rats raised in SL display an overall decrease
in the expression of Pomc gene expression (Srinivasan et al., 2008;
Chen et al., 2009). The observed changes appear to reflect an
acquired mechanism that originates from a malprograming of the
hypothalamic melanocortin system during early life rather than
being a consequence of metabolic dysfunctions, such as overweight
and hyperphagia. Consistent with this idea, changes in POMC
innervation to the PVH are observed as early as during the first
postnatal weeks in neonatally overfed mice, i.e., prior to the devel-
opment of overweight and hyperphagia (Bouret et al., 2007). In
addition to its adverse effects on the Pomc gene expression, post-
natal overfeeding affects the neuronal response to melanocortins.
For example, PVH neurons of chronically overfed pups display
reduced electrophysiological responses to αMSH (Davidowa et al.,
2003).
EPIGENETIC CHANGES
Epigenetic mechanisms of gene regulation, such as DNA methy-
lation and histone modifications (e.g., methylation, acetylation,
ubiquitination) can regulate gene expression in response to envi-
ronmental stimuli. Given that Pomc expression can be affected
by the prenatal or early postnatal diet (see above) many groups
have investigated whether epigenetic modifications of the POMC
promoter occur during the neonatal period in response to nutri-
tional insults. Using a bisulfite sequencing approach, Plagemann
and colleagues studied the methylation status of CpG dinu-
cleotides of the Pomc promoter in rats that were raised in SL
and found that postnatal overfeeding causes hypermethylation of
the Pomc promoter. Interestingly, this hypermethylation occurs
within the two Sp1-related binding sequences of the Pomc pro-
moter (Sp1, NF-KB), which are essential for mediating the effect
of leptin and insulin on Pomc gene expression (Plagemann et al.,
2009). Similarly, recent human studies showed that childhood
obesity is associated with POMC hypermethylation (Kuehnen
et al., 2012). In contrast, methylation of the fetal hypothalamic
Pomc promoter is reduced in underfed sheep, which is associated
with reduced DNA methyltransferase activity and altered histone
methylation and acetylation (Begum et al., 2012). In addition,
rat neonates from protein-restricted dams display a reduction
of hypothalamic Dnmt1 and Dmnt3a mRNA expression (Coupe
et al., 2010).
CONCLUSION
At a time when obesity, including in children, is reaching epi-
demic proportions, it appears crucial to better understand the
biological processes that mediate the development of metabolic
systems. The melanocortin system plays an important role in
this process, and recent studies are providing knowledge on how
POMC- and MC4R-containing neurons develop. These studies
have also revealed that changes in the hormonal and nutritional
milieu during critical periods of life can permanently influence
the development and functional activity of the melanocortin sys-
tem. This finding could represent a key mechanism for effecting
long-term changes in weight regulation in response to perinatal
insults. It also opens new avenues for understanding congenital
eating disorders, such as Prader–Willi syndrome. However, if we
want to design therapeutic interventions to reverse the metabolic
programing of the fetus and/or neonate, it remains to show the
periods of vulnerability for the melanocortin system in humans,
which most likely proceeds on a timeline of months, compared to
days in rodents.
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